Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
196.42
+3.02 (+1.56%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
3,606,987
Open
194.97
Bid (Size)
195.80 (10)
Ask (Size)
196.65 (4)
Prev. Close
193.40
Today's Range
193.94 - 196.61
52wk Range
135.85 - 199.95
Shares Outstanding
N/A
Dividend Yield
3.01%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Spotlight on AbbVie: Analyzing the Surge in Options Activity
Today 16:15 EDT
Via
Benzinga
3 Things You Need to Know if You Buy AbbVie Stock Today
Today 12:05 EDT
This dynamic big pharma is undergoing a few key changes.
Via
The Motley Fool
Performance
YTD
+22.90%
+22.90%
1 Month
+3.42%
+3.42%
3 Month
+15.23%
+15.23%
6 Month
+9.35%
+9.35%
1 Year
+31.79%
+31.79%
More News
Read More
3 No-Brainer Dividend Stocks to Buy in September
September 08, 2024
Via
The Motley Fool
Earn $1,000 Per Month in Dividends From These 4 Stocks
September 07, 2024
Via
The Motley Fool
Peering Into AbbVie's Recent Short Interest
September 06, 2024
Via
Benzinga
Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration
September 05, 2024
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Here's How Much $100 Invested In AbbVie 10 Years Ago Would Be Worth Today
September 05, 2024
Via
Benzinga
AbbVie Options Trading: A Deep Dive into Market Sentiment
August 29, 2024
Via
Benzinga
Got $1,000? 3 Healthcare Stocks to Buy and Hold Forever
September 05, 2024
Via
The Motley Fool
AbbVie Stock Post Humira is Still an Attractive Stock to Hold
September 04, 2024
Via
MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth
September 04, 2024
Via
FinancialNewsMedia
Exposures
COVID-19
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth
September 04, 2024
From
FN Media Group LLC
Via
GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
September 03, 2024
Via
Benzinga
2 Dividend Stocks You Can Safely Hold Through a Recession
September 02, 2024
Via
The Motley Fool
2 High-Yield Dividend Stocks to Buy in September and Hold for a Decade or Longer
September 01, 2024
Via
The Motley Fool
Stock Market Rally Mixed; Dow Jones Hits High While Nvidia Tumbles On Earnings: Weekly Review
August 30, 2024
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
2 Monster Stocks You Can Buy Right Now Before They Surge Even Higher
August 30, 2024
Via
The Motley Fool
3 Rock-Solid Pharma Stocks to Buy Now and Hold Forever
August 30, 2024
Via
The Motley Fool
2 Incredibly Cheap Healthcare Stocks to Buy Now
August 30, 2024
Via
The Motley Fool
Biotech And Life Science Sector Update Summer Of 2024
August 29, 2024
Via
Talk Markets
Bull Market Buys: 3 Dividend Stocks to Own for the Long Run
August 29, 2024
Via
The Motley Fool
As Regulators Gear Up To Decide On Bristol Myers' Schizophrenia Treatment, Neurocrine Biosciences' Data Disappoints Investors
August 28, 2024
Via
Benzinga
Neurocrine Bio Dives As Schizophrenia Trial Results Lags Peers
August 28, 2024
Via
Investor's Business Daily
3 Best Growth Stocks to Own for the Next 10 Years
August 28, 2024
Via
MarketBeat
Topics
Economy
Exposures
Economy
Prediction: Eli Lilly's Latest Move Will Threaten AbbVie Stock
August 28, 2024
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.